Allergies News and Research

Latest Allergies News and Research

People with food allergies less likely to become infected with SARS-CoV-2, study finds

A National Institutes of Health-funded study has found that people with food allergies are less likely to become infected with SARS-CoV-2, the virus that causes COVID-19, than people without them. In addition, while previous research identified obesity as a risk factor for severe COVID-19, the new study has identified obesity and high body mass index (BMI) as associated with increased risk for SARS-CoV-2 infection.

1 Jun 2022

Study analyzes how four types of COVID-19 vaccines prepare the body to fight SARS-CoV-2

Scientists at La Jolla Institute for Immunology have published the first analysis of how four types of COVID-19 vaccines prepare the body to fight SARS-CoV-2.

31 May 2022

New evidence confirms that enterovirus D68 causes acute flaccid myelitis

A case report published in the New England Journal of Medicine provides evidence that enterovirus D68 directly infects spinal cord neurons and that a corresponding robust immune response is present – a direct causation to the polio-like paralyzing illness, acute flaccid myelitis (AFM).

26 May 2022

Scientists discover a gene defect that results in allergic and autoimmune disease

Inflammation of the skin and the esophagus, food allergy and asthma are just some of the symptoms of a now 12-year-old boy who was the first to have a mutation on the IL-33 gene. An international team led by a physician from the Karl Landsteiner University for Health Sciences, Krems, discovered this new disease entity.

26 May 2022

Longer period of exclusive breastfeeding linked with decreased odds of childhood asthma

Pregnant women and new mothers are often presented with information on the benefits of breastfeeding their infants.

25 May 2022

STIs could be prevented with a dose of doxycycline after unprotected sex

A significant proportion of bacterial sexually transmitted infections (STIs) - gonorrhea, chlamydia or syphilis - were prevented with a dose of doxycycline after unprotected sex, according to preliminary results of a clinical trial that closed early because it was very effective for men who have sex with men and transgender women who are living with HIV or are taking HIV pre-exposure prophylaxis (PrEP).

25 May 2022

Key immunological changes that support peanut allergy remission in children discovered

Australian researchers have discovered the key immunological changes that support the remission of peanut allergy in children, paving the way for new, more targeted treatments.

25 May 2022

Researcher from The University of Colorado Anschutz Medical Campus to receive DeNovix Platinum Edition CellDrop

DeNovix Inc. is pleased to announce the winner of the Platinum Edition CellDrop Giveaway: Dr. Christina Roark from The University of Colorado Anschutz Medical Campus, USA! Selected at random from thousands of entries from scientists worldwide, the CellDrop will be housed in Dr. Roark’s lab in the Allergy and Clinical Immunology Division in the Department of Medicine.

From DeNovix Inc. 24 May 2022

Using microfluidics and magnets to isolate rare, allergen-reactive white blood cells

Across the world, food allergies are on the rise. One of the most important cells in studying this ailment are basophils, which activate inflammation and other responses to allergens such as rashes, and sometimes, anaphylaxis.

23 May 2022

UVA scientists make progress in their longstanding efforts to combat tuberculosis

As headlines focus on COVID-19 and, now, monkeypox, tuberculosis remains one of the great scourges of infectious disease around the world. Approximately 1.5 million people died of tuberculosis in 2020, the World Health Organization reports.

23 May 2022

University of Minnesota receives $66 million to establish new antiviral drug discovery center

The University of Minnesota has received $66 million from the National Institute of Allergy and Infectious Diseases to establish a center to develop antiviral drugs for pandemic-level viruses, including SARS-CoV-2.

23 May 2022

Researchers discover how one type of T cell creates functionally distinct, but genetically identical daughter cells

Scientists at St. Jude Children's Research Hospital have solved an immunology puzzle. A CD8+ T cell can have two functionally distinct daughter cells after it divides, despite the cells being genetically identical.

20 May 2022

UNC-Chapel Hill secures $65 million NIH grant for establishing Antiviral Drug Discovery Center

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health awarded the UNC Gillings School of Global Public Health a $65 million grant establishing an Antiviral Drug Discovery Center to develop oral antivirals that can combat pandemic-level viruses like COVID-19.

20 May 2022

Probiotic supplements accelerate the maturation of microbiome in extremely preterm infants

University of Calgary researchers have shown probiotic supplements can help form a healthy microbiome in the gut of the tiniest infants who are born without a fully formed gut microbiome.

20 May 2022

Studies provide insight into how long COVID-19 immunity lasts and nature of immune recall

How does the immune system remember and recognize viral invaders it has encountered in the past? A trio of newly published studies of people infected with SARS-CoV-2, vaccinated against the virus or both, are providing tantalizing new clues about the factors that influence the speed and magnitude of the immune system's response to subsequent infection with variants of SARS-CoV-2.

19 May 2022

Allergies News and Research

Latest Allergies News and Research

People with food allergies less likely to become infected with SARS-CoV-2, study finds

Study analyzes how four types of COVID-19 vaccines prepare the body to fight SARS-CoV-2

New evidence confirms that enterovirus D68 causes acute flaccid myelitis

Scientists discover a gene defect that results in allergic and autoimmune disease

Longer period of exclusive breastfeeding linked with decreased odds of childhood asthma

STIs could be prevented with a dose of doxycycline after unprotected sex

Key immunological changes that support peanut allergy remission in children discovered

Researcher from The University of Colorado Anschutz Medical Campus to receive DeNovix Platinum Edition CellDrop

Using microfluidics and magnets to isolate rare, allergen-reactive white blood cells

UVA scientists make progress in their longstanding efforts to combat tuberculosis

University of Minnesota receives $66 million to establish new antiviral drug discovery center

Researchers discover how one type of T cell creates functionally distinct, but genetically identical daughter cells

UNC-Chapel Hill secures $65 million NIH grant for establishing Antiviral Drug Discovery Center

Probiotic supplements accelerate the maturation of microbiome in extremely preterm infants

Studies provide insight into how long COVID-19 immunity lasts and nature of immune recall

New funding boost to combat antibiotic resistance

Genome research explains why oats could be suitable for most people with celiac disease

NIH awards $577 million to establish AViDD Centers for Pathogens of Pandemic Concern

Researchers explore COVID-19 vaccination in immunocompromised individuals

Allergic asthma, allergies may be associated with the risk of cardiovascular diseases

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Allergies News and Research

Latest Allergies News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in